These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 27498356)

  • 1. Dysfunction of endothelial progenitor cells is associated with the type I IFN pathway in patients with polymyositis and dermatomyositis.
    Ekholm L; Kahlenberg JM; Barbasso Helmers S; Tjärnlund A; Yalavarthi S; Zhao W; Seto N; Betteridge Z; Lundberg IE; Kaplan MJ
    Rheumatology (Oxford); 2016 Nov; 55(11):1987-1992. PubMed ID: 27498356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The host defense peptide LL-37 a possible inducer of the type I interferon system in patients with polymyositis and dermatomyositis.
    Lu X; Tang Q; Lindh M; Dastmalchi M; Alexanderson H; Popovic Silwerfeldt K; Agerberth B; Lundberg IE; Wick C
    J Autoimmun; 2017 Mar; 78():46-56. PubMed ID: 28012697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 10 hampers endothelial cell differentiation and enhances the effects of interferon α on lupus endothelial cell progenitors.
    Cates AM; Holden VI; Myers EM; Smith CK; Kaplan MJ; Kahlenberg JM
    Rheumatology (Oxford); 2015 Jun; 54(6):1114-23. PubMed ID: 25416712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of Interleukin 21 and Interleukin 21 Receptor in Patients with Dermatomyositis and Polymyositis.
    Liu T; Hou Y; Dai TJ; Yan CZ
    Chin Med J (Engl); 2017 Sep; 130(17):2101-2106. PubMed ID: 28836555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced miR-146a Promotes REG3A Expression and Macrophage Migration in Polymyositis and Dermatomyositis.
    Jiang T; Huang Y; Liu H; Xu Q; Gong Y; Chen Y; Hu X; Han Z; Gao M
    Front Immunol; 2020; 11():37. PubMed ID: 32153557
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased Expression of the NOD-like Receptor Family, Pyrin Domain Containing 3 Inflammasome in Dermatomyositis and Polymyositis is a Potential Contributor to Their Pathogenesis.
    Yin X; Han GC; Jiang XW; Shi Q; Pu CQ
    Chin Med J (Engl); 2016 May; 129(9):1047-52. PubMed ID: 27098789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial progenitor dysfunction associates with a type I interferon signature in primary antiphospholipid syndrome.
    Grenn RC; Yalavarthi S; Gandhi AA; Kazzaz NM; Núñez-Álvarez C; Hernández-Ramírez D; Cabral AR; McCune WJ; Bockenstedt PL; Knight JS
    Ann Rheum Dis; 2017 Feb; 76(2):450-457. PubMed ID: 27432357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-18 overexpression as a hallmark of the activity of autoimmune inflammatory myopathies.
    Tucci M; Quatraro C; Dammacco F; Silvestris F
    Clin Exp Immunol; 2006 Oct; 146(1):21-31. PubMed ID: 16968394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Utility of an Enzyme-Linked Immunosorbent Assay for Detecting Anti-Melanoma Differentiation-Associated Gene 5 Autoantibodies.
    Sato S; Murakami A; Kuwajima A; Takehara K; Mimori T; Kawakami A; Mishima M; Suda T; Seishima M; Fujimoto M; Kuwana M
    PLoS One; 2016; 11(4):e0154285. PubMed ID: 27115353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies.
    Lundberg I; Ulfgren AK; Nyberg P; Andersson U; Klareskog L
    Arthritis Rheum; 1997 May; 40(5):865-74. PubMed ID: 9153548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-6 and type I interferon-regulated genes and chemokines mark disease activity in dermatomyositis.
    Bilgic H; Ytterberg SR; Amin S; McNallan KT; Wilson JC; Koeuth T; Ellingson S; Newman B; Bauer JW; Peterson EJ; Baechler EC; Reed AM
    Arthritis Rheum; 2009 Nov; 60(11):3436-46. PubMed ID: 19877033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Study Based on the Correlation Between Slit2/Robo1 Signaling Pathway Proteins and Polymyositis/Dermatomyositis.
    Chai KX; Chen YQ; Kong LS; Fan PL; Yuan X; Yang J
    Curr Mol Med; 2020; 20(9):717-722. PubMed ID: 32213157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anatomic localization of immature and mature dendritic cell subsets in dermatomyositis and polymyositis: Interaction with chemokines and Th1 cytokine-producing cells.
    Page G; Chevrel G; Miossec P
    Arthritis Rheum; 2004 Jan; 50(1):199-208. PubMed ID: 14730617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between disease activity and type 1 interferon- and other cytokine-inducible gene expression in blood in dermatomyositis and polymyositis.
    Greenberg SA; Higgs BW; Morehouse C; Walsh RJ; Kong SW; Brohawn P; Zhu W; Amato A; Salajegheh M; White B; Kiener PA; Jallal B; Yao Y
    Genes Immun; 2012 Apr; 13(3):207-13. PubMed ID: 21881594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunolocalization of interleukin-1 receptors in the sarcolemma and nuclei of skeletal muscle in patients with idiopathic inflammatory myopathies.
    Grundtman C; Salomonsson S; Dorph C; Bruton J; Andersson U; Lundberg IE
    Arthritis Rheum; 2007 Feb; 56(2):674-87. PubMed ID: 17265504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenic aspects of dermatomyositis, polymyositis and overlap myositis.
    Gherardi RK
    Presse Med; 2011 Apr; 40(4 Pt 2):e209-18. PubMed ID: 21376512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of Notch signaling in diabetic endothelial progenitor cells dysfunction.
    Sukmawati D; Tanaka R; Ito-Hirano R; Fujimura S; Hayashi A; Itoh S; Mizuno H; Daida H
    J Diabetes Complications; 2016; 30(1):12-20. PubMed ID: 26598222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tim-3, PD-1, CD244 and Foxp3 Positive T Cells' Relation to the Prognosis of Dermatomyositis and Polymyositis Patients.
    Ye J; Liu Q; Fu Q; Li B; Huang J; Zeng G
    J Coll Physicians Surg Pak; 2023 Apr; 33(4):421-426. PubMed ID: 37190715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated serum levels of interleukin-1 receptor antagonist in polymyositis/dermatomyositis. A biologic marker of disease activity with a possible role in the lack of acute-phase protein response.
    Gabay C; Gay-Croisier F; Roux-Lombard P; Meyer O; Maineti C; Guerne PA; Vischer T; Dayer JM
    Arthritis Rheum; 1994 Dec; 37(12):1744-51. PubMed ID: 7986220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell receptor-mediated characteristic signaling pathway of peripheral blood T cells in dermatomyositis and polymyositis.
    Shimojima Y; Matsuda M; Ishii W; Kishida D; Sekijima Y
    Autoimmunity; 2017 Dec; 50(8):481-490. PubMed ID: 29172719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.